Home›Stock Screener›Aurobindo Pharma›P/E Ratio

Aurobindo Pharma P/E Ratio

Current P/E Ratio
25.88
High Valuation
High - Growth expectations or overvalued

Aurobindo Pharma (AUROPHARMA) P/E ratio is 25.88 (High), EPS (TTM) ₹60.34, current price ₹1734.00 on NSE vs historical average P/E of 16.78 (100.0th percentile) — High - Growth expectations or overvalued. Also explore AUROPHARMA share price history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 25.88
Current Price ₹1734.00
EPS (TTM) ₹60.34
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 16.78
Historical Range 4.98 - 22.54
Percentile 100.0%

Sector Context

Sector Average 56.89
Sector Median 32.06
Sector Rank #11 of 199
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹63.89
Mar 2026 ₹15.86
Jun 2026 ₹17.86

AUROPHARMA P/E Ratio — Valuation Signal & Historical Context

Aurobindo Pharma P/E 25.88 vs historical average 16.78, range 4.98–22.54 — signal: Overvalued.

  • Stock appears overvalued with PE of 25.88, suggesting caution for new investments
  • Current PE is 54.3% above historical average
  • Trading at discount to sector average PE of 56.89

Aurobindo Pharma P/E Ratio Historical Trend

AUROPHARMA annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 25.88 vs historical average 16.78. For live price, revenue and the complete fundamental profile, see AUROPHARMA stock price BSE.

AUROPHARMA Historical P/E Ratio — EPS, Year-End Price & Valuation

Aurobindo Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 22.54 60.04 ₹1353.25 NSE Moderate
2024 18.07 59.76 ₹1080.15 NSE Moderate
2023 9.2 47.25 ₹434.80 NSE Low
2022 21.48 34.09 ₹732.10 NSE Moderate
2021 18.93 49.02 ₹927.75 NSE Moderate
2020 4.98 91.91 ₹458.10 NSE Low
2019 16.74 43.8 ₹733.15 NSE Moderate
2018 17.36 39.39 ₹683.95 NSE Moderate
2017 16.3 41.44 ₹675.50 NSE Moderate
2016 22.16 39.77 ₹881.40 NSE Moderate

AUROPHARMA vs Healthcare Peers — P/E Ratio Comparison

Aurobindo Pharma P/E 25.88 vs Healthcare average 56.89, median 32.06 — range 1.99–747.21.

Sector Average
56.89
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 1.99 ₹66 Low
Murae Organisor MURAE 2.86 ₹41 Low
Colinz Laboratories COLINZ 3.27 ₹9 Low
Phaarmasia PHRMASI 3.41 ₹59 Low
Sun Pharma Advanced Rese… SPARC 4.03 ₹6,361 Low
Dipna Pharmachem DPL 4.65 ₹12 Low
JFL Life Sciences JFLLIFE 4.95 ₹67 Low
Shelter Pharma SHELTER 5.71 ₹56 Low
GKB Ophthalmics GKB 5.9 ₹33 Low
Kabra Drugs KABRADG 6.29 ₹49 Low